Related Experiment Video
Updated: May 30, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Ex vivo cancer chemoprevention research possibilities
E Ann Hudson1, Louise H Fox, Jeni C A Luckett
1Cancer Biomarkers and Prevention Group, Departments of Biochemistry and Cancer Studies and Molecular Medicine, Biocentre, University of Leicester, Leicester LE1 7RH, UK.
Abstract:
The concept of cancer prevention with naturally occurring or synthetic compounds is rapidly gaining momentum as a key field in cancer research. The availability of good models for the determination of the molecular mechanisms of these agents, which frequently have multiple sites of action within a cell, is key to the progression of the field. In this review, we concentrate on the emergence of several in vitro techniques that have significant advantages over more traditional monolayer cell culture, and/or in vivo models. In particular, we focus on the potential of 3D multicellular spheroid models as versatile intermediates between monolayer culture and tumours in situ. In these models, cell-cell interactions and cell-extracellular matrix interactions can closely mimic the environment to which tumour cells would be exposed in vivo, while maintaining the advantages of ease of manipulation of an in vitro system. The in vitro tube formation assay for the study of angiogenesis, the availability of human tissues for research, and the sophisticated technology surrounding DNA microarray and proteomics are also briefly discussed.
Insights
Cancer prevention research is advancing with new in vitro models. Three-dimensional multicellular spheroids offer a realistic yet manageable system for studying cancer-fighting compounds and their mechanisms.
Area of Science:
- Oncology
- Cell Biology
- Pharmacology
Background:
- Cancer prevention research is a rapidly growing field.
- Understanding the molecular mechanisms of cancer-preventive agents is crucial.
- Traditional cell culture and in vivo models have limitations.
Purpose of the Study:
- To review emerging in vitro techniques for studying cancer prevention.
- To highlight the advantages of 3D multicellular spheroid models.
- To discuss other relevant in vitro methods and technologies.
Main Methods:
- Focus on 3D multicellular spheroid models as advanced in vitro systems.
- Discuss in vitro tube formation assays for angiogenesis research.
- Mention the use of human tissues, DNA microarray, and proteomics.
Main Results:
- 3D spheroid models closely mimic in vivo tumor microenvironments.
- These models facilitate the study of cell-cell and cell-extracellular matrix interactions.
- The reviewed techniques offer improved insights compared to traditional methods.
Conclusions:
- 3D multicellular spheroids represent a significant advancement in cancer research models.
- These models bridge the gap between simple cell cultures and complex in vivo systems.
- Emerging in vitro technologies enhance the study of cancer prevention strategies.
More Related Videos
13:17In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology
Published on: September 29, 2023
08:29Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
Published on: October 2, 2014
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Prevention
Some...
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...